Breaking News Instant updates and real-time market news.

GTHX

G1 Therapeutics

$35.55

1.32 (3.86%)

09:15
03/13/18
03/13
09:15
03/13/18
09:15

G1 Therapeutics price target raised to $42 from $34 at Needham

Needham analyst Chad Messer raised his price target on G1 Therapeutics to $42 after the company reported a "strong" top line data for trilaciclib last week showing significant reduction in treatment emergent adverse events when added to chemotherapy. Messer keeps his Buy rating on G1 Therapeutics and attributes the price increase to the base case trilaciclib market forecast, adding that his sales forecasts are based on U.S. sales expectations alone even though G1 can partner on the rights to its programs internationally.

GTHX G1 Therapeutics
$35.55

1.32 (3.86%)

02/05/18
JPMS
02/05/18
NO CHANGE
Target $30
JPMS
Overweight
G1 Therapeutics price target raised to $30 from $24 at JPMorgan
JPMorgan analyst Anupam Rama raised his price target for G1 Therapeutics to $30 ahead of the trilaciclib Phase 2 data for the treatment of front-line small cell lung cancer. The analyst continues to view trilaciclib as a "differentiated underappreciated asset." He also continues to see a "high probability of an upside scenario" ranging from 30%-50%. Downside in the stock could range from 15%-20% on mixed data to 35%-plus if trilaciclib is taken out of the model completely, Rama tells investors in a research note.
12/19/17
BTIG
12/19/17
INITIATION
Target $38
BTIG
Buy
G1 Therapeutics initiated with a Buy at BTIG
BTIG analyst Dane Leone started G1 Therapeutics with a Buy rating and $38 price target.
06/12/17
WEDB
06/12/17
INITIATION
WEDB
Outperform
G1 Therapeutics initiated with an Outperform at Wedbush
Wedbush analyst David M. Nierengarten started coverage of G1 Therapeutics with a $33 price target and an Outperform rating. He says that the company's two lead programs based on CDK 4/6 inhibition have "compelling" opportunities and both can generate sales of more than $1B. Designed to prevent division of bone marrow stem cells, Trilaciclib has been shown to be effective while having "none of the complications" associated with HGF therapy, according to the analyst. G1T38 "could be safer and more potent than Ibrance, which generated more than $2B in sales last year" according to the analyst.
06/12/17
NEED
06/12/17
INITIATION
Target $34
NEED
Buy
G1 Therapeutics initiated with a Buy at Needham
Needham analyst Chad Messer started G1 Therapeutics with a Buy rating and $34 price target, noting that the company's lead cancer drug programs are still relatively early stage but he sees "multiple opportunities" for shares to advance through the first half of next year as the company reports data from trials.

TODAY'S FREE FLY STORIES

BA

Boeing

$375.07

2.97 (0.80%)

15:05
03/19/19
03/19
15:05
03/19/19
15:05
Periodicals
Breaking Periodicals news story on Boeing »

DOT asks Inspector…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 28

    May

TME

Tencent Music

$19.33

0.2 (1.05%)

15:04
03/19/19
03/19
15:04
03/19/19
15:04
Options
Tencent options imply 12.9% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

NAII

Natural Alternatives International

$11.20

-0.17 (-1.50%)

15:01
03/19/19
03/19
15:01
03/19/19
15:01
Hot Stocks
Natural Alternatives says Court of Appeals rules in its favor in patent suit »

Natural Alternatives…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:00
03/19/19
03/19
15:00
03/19/19
15:00
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

KEM

Kemet

$18.34

0.02 (0.11%)

14:56
03/19/19
03/19
14:56
03/19/19
14:56
Conference/Events
Kemet management to meet with B. Riley FBR »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

DBD

Diebold

$11.07

-0.33 (-2.89%)

14:55
03/19/19
03/19
14:55
03/19/19
14:55
Options
Diebold put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMD

AMD

$25.68

2.43 (10.45%)

, GOOG

Alphabet

$1,195.81

12.15 (1.03%)

14:54
03/19/19
03/19
14:54
03/19/19
14:54
Hot Stocks
AMD says Radeon GPUs being used for Google Stadia platform »

AMD (AMD) announced that…

AMD

AMD

$25.68

2.43 (10.45%)

GOOG

Alphabet

$1,195.81

12.15 (1.03%)

GOOGL

Alphabet Class A

$1,199.72

11.63 (0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 04

    Apr

  • 29

    Apr

  • 29

    Apr

  • 27

    Oct

SIEN

Sientra

$9.26

0.05 (0.54%)

14:51
03/19/19
03/19
14:51
03/19/19
14:51
Hot Stocks
Breaking Hot Stocks news story on Sientra »

Sientra down 6% after FDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WNS

WNS Holdings

$52.87

-0.14 (-0.26%)

14:50
03/19/19
03/19
14:50
03/19/19
14:50
Conference/Events
WNS Holdings management to meet with Wedbush »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 26

    Mar

JCOM

j2 Global

$86.67

0.76 (0.88%)

14:49
03/19/19
03/19
14:49
03/19/19
14:49
Conference/Events
j2 Global management to meet with Wedbush »

Luncheon and Dinner…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

FDX

FedEx

$182.02

-0.4 (-0.22%)

14:49
03/19/19
03/19
14:49
03/19/19
14:49
Options
Fedex options imply 8.9% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 01

    Apr

  • 02

    Apr

SIEN

Sientra

$9.26

0.05 (0.54%)

14:48
03/19/19
03/19
14:48
03/19/19
14:48
Hot Stocks
FDA posts warning letter sent to Sientra »

In a letter dated March…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMASY

Inmarsat

$0.00

(0.00%)

14:46
03/19/19
03/19
14:46
03/19/19
14:46
Hot Stocks
Inmarsat confirms receipt of potential $7.21 per share offer from PE consortium »

The Board of Inmarsat…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$269.61

0.15 (0.06%)

14:45
03/19/19
03/19
14:45
03/19/19
14:45
Periodicals
Tesla, Musk face dozens of suits, probes, CNBC says »

Tesla and CEO Elon Musk…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

GLUU

Glu Mobile

$10.46

0.59 (5.98%)

14:45
03/19/19
03/19
14:45
03/19/19
14:45
Options
Glu Mobile call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

NOVT

Novanta

$83.83

-0.1 (-0.12%)

14:41
03/19/19
03/19
14:41
03/19/19
14:41
Conference/Events
Novanta management to meet with William Blair »

Meeting to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

  • 09

    May

AXL

American Axle

$14.66

0.305 (2.13%)

14:35
03/19/19
03/19
14:35
03/19/19
14:35
Options
American Axle put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:30
03/19/19
03/19
14:30
03/19/19
14:30
General news
Oil Action: WTI crude »

Oil Action: WTI crude…

BUD

AB InBev

$83.96

1.92 (2.34%)

, MO

Altria Group

$57.06

-0.245 (-0.43%)

14:25
03/19/19
03/19
14:25
03/19/19
14:25
Periodicals
AB InBev to name former Altria CEO as Chairman, WSJ reports »

This week, Anheuser-Busch…

BUD

AB InBev

$83.96

1.92 (2.34%)

MO

Altria Group

$57.06

-0.245 (-0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 20

    Mar

  • 07

    May

  • 16

    May

14:25
03/19/19
03/19
14:25
03/19/19
14:25
General news
CEA released the Economic Report of the President earlier »

CEA released the Economic…

FB

Facebook

$162.92

2.46 (1.53%)

, AMZN

Amazon.com

$1,780.97

38.97 (2.24%)

14:23
03/19/19
03/19
14:23
03/19/19
14:23
Periodicals
Instagram impinges on Amazon, others with new shopping functionality, WSJ says »

Instagram (FB), in a push…

FB

Facebook

$162.92

2.46 (1.53%)

AMZN

Amazon.com

$1,780.97

38.97 (2.24%)

SHOP

Shopify

$201.68

-4.17 (-2.03%)

WMT

Walmart

$99.96

0.29 (0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 20

    Mar

  • 26

    Mar

  • 27

    Mar

  • 04

    Apr

  • 16

    May

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$283.22

0.76 (0.27%)

14:22
03/19/19
03/19
14:22
03/19/19
14:22
Hot Stocks
Trump says trade talks with China 'going very well' »

While walking away from a…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$283.22

0.76 (0.27%)

GOOG

Alphabet

$1,194.43

10.77 (0.91%)

GOOGL

Alphabet Class A

$1,198.48

10.39 (0.87%)

FB

Facebook

$162.98

2.52 (1.57%)

TWTR

Twitter

$31.36

0.265 (0.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 04

    Apr

  • 23

    Apr

  • 29

    Apr

  • 29

    Apr

  • 27

    Oct

TSG

The Stars Group

$17.01

0.05 (0.29%)

14:20
03/19/19
03/19
14:20
03/19/19
14:20
Options
Call buyers opening in Stars Group as shares tick higher »

Call buyers opening in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
03/19/19
03/19
14:17
03/19/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
03/19/19
03/19
14:16
03/19/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.